Common use of QuadraMed SEC Filings Clause in Contracts

QuadraMed SEC Filings. The QuadraMed SEC Filings, copies of which have been furnished to each of the Shareholders, have been duly filed, were in substantial compliance with the requirements of their respective report forms, were complete and correct in all material respects as of the dates at which the information therein was furnished, as of such date, contained no untrue statement of a material fact nor omitted to state a material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. The consolidated financial statements of QuadraMed and the related notes and schedules included in the QuadraMed SEC Filings comply in all material respects with the requirements of the Exchange Act and present fairly the consolidated financial position in accordance with generally accepted accounting principles of QuadraMed, as of the dates indicated, and the results of its operations and changes in financial position for the periods therein specified (subject, in the case of unaudited interim financial statements, to normal year-end adjustments). Since the date of the filing with the SEC of QuadraMed's most recent 10-Q, there has been no material adverse change in the financial condition or results of operations of QuadraMed that has resulted in a Material Adverse Effect on QuadraMed.

QuadraMed SEC Filings. The QuadraMed SEC Filings, copies of which have been furnished to each of the ShareholdersStockholder, have been duly filed, were in substantial compliance with the requirements of their respective report forms, were complete and correct in all material respects as of the dates at which the information therein was furnished, as of such date, contained no untrue statement of a material fact nor omitted to state a material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. The consolidated financial statements of QuadraMed and the related notes and schedules included in the QuadraMed SEC Filings comply in all material respects with the requirements of the Exchange Act and present fairly the consolidated financial position in accordance with generally accepted accounting principles of QuadraMed, as of the dates indicated, and the results of its operations and changes in financial position for the periods therein specified (subject, in the case of unaudited interim financial statements, to normal year-end adjustments). Since the date of the filing with the SEC of QuadraMed's most recent 10-Q, there has been no material adverse change in the financial condition or results of operations of QuadraMed that has resulted in a Material Adverse Effect on QuadraMed.

QuadraMed SEC Filings. QuadraMed has furnished to RHP a true and complete copy of the QuadraMed SEC Filings made since September 30, 1997, and, prior to the Effective Time, QuadraMed shall promptly furnish to RHP a true and complete copy of any additional QuadraMed SEC Filings. The QuadraMed SEC Filings, true, correct and complete copies of which have been furnished to each of the ShareholdersRHP, have been duly filed, were in substantial compliance with the requirements of their respective report forms, were complete and correct in all material respects as of the dates at which the information therein was furnishedunder the respective forms were furnished and contained, as of such date, contained no do not contain an untrue statement of a material fact nor omitted omit to state a material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, therein not misleading, and since September 30, 1997, there has not been any Material Adverse Effect. The consolidated financial statements of QuadraMed and the related notes and schedules included in the QuadraMed SEC Filings comply in all material respects fully with the requirements of the Exchange Act and present fairly the consolidated financial position of QuadraMed in accordance with generally accepted accounting principles of QuadraMedconsistently applied, as of the dates indicated, and the results of its operations and changes in financial position for the periods therein specified (subject, in the case of unaudited interim financial statements, to normal year-end adjustments). Since the date The QuadraMed SEC Filings constitute all of the filing with the SEC of QuadraMed's most recent 10-Qdocuments required by applicable securities laws to be filed by it and all such reports have been true, there has been no complete and correct in all material adverse change in the financial condition or results of operations of QuadraMed that has resulted in a Material Adverse Effect on QuadraMedrespects.

QuadraMed SEC Filings. The QuadraMed SEC Filings, copies of which have been furnished to each of the ShareholdersStockholders, have been duly filed, were in substantial compliance with the requirements of their respective report formsforms in all material respects, were complete and correct in all material respects as of the dates at which the information therein was furnished, as of such date, contained no untrue statement of a material fact nor omitted to state a material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. The consolidated financial statements of QuadraMed and the related notes and schedules included in the QuadraMed SEC Filings comply in all material respects with the requirements of the Exchange Act and present fairly the consolidated financial position in accordance with generally accepted accounting principles of QuadraMed, as of the dates indicated, and the results of its operations and changes in financial position for the periods therein specified (subject, in the case of unaudited interim financial statements, to normal year-end adjustments). Since the date of the filing with the SEC of QuadraMed's most recent 10-Q, there has been no material adverse change in the financial condition or results of operations of QuadraMed that has resulted in a Material Adverse Effect on QuadraMed.

QuadraMed SEC Filings. The QuadraMed SEC Filings, copies of which have been furnished to each of the ShareholdersCompany, have been duly filed, were in substantial compliance with the requirements of their respective report forms, were complete and correct in all material respects as of the dates at which the information therein was furnished, as of such date, contained no untrue statement of a material fact nor omitted to state a material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. The consolidated financial statements of QuadraMed and the related notes and schedules included in the QuadraMed SEC Filings comply in all material respects with the requirements of the Exchange Act and present fairly the consolidated financial position in accordance with generally accepted accounting principles of QuadraMed, as of the dates indicated, and the results of its operations and changes in financial position for the periods therein specified (subject, in the case of unaudited interim financial statements, to normal year-end adjustments). Since the date of the filing with the SEC of QuadraMed's most recent 10-Q, there has been no material adverse change in the financial condition or results of operations of QuadraMed that has resulted in a Material Adverse Effect on QuadraMed.

QuadraMed SEC Filings. The QuadraMed SEC Filings, copies of which have been furnished to each of the ShareholdersStockholders, have been duly filed, were in substantial compliance with the requirements of their respective report forms, were complete and correct in all material respects as of the dates at which the information therein was furnished, as of such date, contained no untrue statement of a material fact nor omitted to state a material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. The consolidated financial statements of QuadraMed and the related notes and schedules included in the QuadraMed SEC Filings comply in all material respects with the requirements of the Exchange Act and present fairly the consolidated financial position in accordance with generally accepted accounting principles of QuadraMed, as of the dates indicated, and the results of its operations and changes in financial position for the periods therein specified (subject, in the case of unaudited interim financial statements, to normal year-end adjustments). Since the date of the filing with the SEC of QuadraMed's most recent 10-Q, there has been no material adverse change in the financial condition or results of operations of QuadraMed that has resulted in a Material Adverse Effect on QuadraMed.

QuadraMed SEC Filings. QuadraMed has furnished to RHP a true and complete copy of the QuadraMed SEC Filings made since September 30, 1997, and, prior to the Effective Time, QuadraMed shall promptly furnish to RHP a true and complete copy of any additional QuadraMed SEC Filings. The QuadraMed SEC Filings, true, correct and complete copies of which have been furnished to each of the ShareholdersRHP, have been duly filed, were in substantial compliance with the requirements of their respective report forms, were complete and correct in all material respects as of the dates at which the information therein was furnishedunder the respective forms were furnished and contained, as of such date, contained no do not contain an untrue statement of a material fact nor omitted omit to state a material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, therein not misleading, and since September 30, 1997, there has not been any Material Adverse Effect. The consolidated financial statements of QuadraMed and the related notes and schedules included in the QuadraMed SEC Filings comply in all material respects fully with the requirements of the Exchange Act and present fairly the consolidated financial position of Quadramed in accordance with generally accepted accounting principles of QuadraMedconsistently applied, as of the dates indicated, and the results of its operations and changes in financial position for the periods therein specified (subject, in the case of unaudited interim financial statements, to normal year-end adjustments). Since the date The QuadraMed SEC Filings constitute all of the filing with the SEC of QuadraMed's most recent 10-Qdocuments required by applicable securities laws to be filed by it and all such reports have been true, there has been no complete and correct in all material adverse change in the financial condition or results of operations of QuadraMed that has resulted in a Material Adverse Effect on QuadraMedrespects.